News

FDA approves second BD Rx generic injectable drug

BY Alaric DeArment

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a second product in BD’s new line of injectable drugs, the company said Tuesday.

BD Rx, the pharmaceutical arm of the medical technology manufacturer, whose name stands for Becton, Dickinson and Co., received FDA approval for metoclopramide, part of its BD Simplist line of ready-to-administer pre-filled generic injectables. The product is an antiemetic, a drug used to stop vomiting.

The company previously launched BD Simplist diphenhydramine hydrochloride injection, an antihistamine, last month. The company plans to launch 20 to 30 products in the line over the next few years.

"After a successful launch of BD Simplist pre-filled injectables, we’re excited to be coming out with a second drug that is commonly used by clinicians," BD Rx president Mark Sebree said. "This is just the beginning of our new line of pre-filled injectable products."

The company said that every injection carries the potential for medication error, but while traditional vial and syringe injections, clinicians perform up to 20 steps; with the BD Simplist syringes, the sequence is reduced to about 12 steps.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Warner Chilcott receives FDA approval for Minastrin 24 FE

BY Alaric DeArment

DUBLIN — The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.

Warner Chilcott announced the approval of Minastrin 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) for prevention of pregnancy.

The drug maker said an unnamed third-party company would manufacture the drug, but it did not expect to launch it this year.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Twelve pharmacy schools receive more than $200,000 in money for scholarships

BY Alaric DeArment

ARLINGTON, Va. — The National Association of Chain Drug Stores’ charitable arm has awarded $230,000 in scholarships to pharmacy students, the organization said Tuesday.

The NACDS Foundation said it gave awards ranging from $10,000 to $40,000 to pharmacy schools’ scholarship funds through its Pharmacy Partners Scholarship Program. The awards will provide financial assistance to students working toward doctor of pharmacy degrees.

This year’s award recipients were selected from 48 applicants and were supported by 27 benefactors that included NACDS chain members and associate members. The recipients, awards and benefactors included:

  • University of Iowa College of Pharmacy, $40,000, Wayne Roberts Memorial Scholarship;
  • University of Pittsburgh School of Pharmacy, $30,000, Lilly USA LLC Scholarship;
  • University of Toledo College of Pharmacy and Pharmaceutical Sciences, $20,000, Boehringer Ingelheim Pharmaceuticals.

The NACDS Foundation gave out the following awards:

  • Massachusetts College of Pharmacy and Health Sciences University School of Pharmacy – Boston, $20,000;
  • University of Texas at Austin College of Pharmacy, $30,000;
  • University of Oklahoma College of Pharmacy, $20,000;
  • University of Tennessee Health Science Center College of Pharmacy, $20,000;
  • Duquesne University Mylan School of Pharmacy, $10,000;
  • Southern Illinois University Edwardsville School of Pharmacy, $10,000;
  • University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences, $10,000;
  • West Virginia University School of Pharmacy, $10,000;
  • Western New England University College of Pharmacy, $10,000.

Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?